Simeone SM, Li MW, Paradis P, Schiffrin EL. Vascular gene expression in mice overexpressing human endothelin-1 targeted to the endothelium. Physiol Genomics 43: 148 -160, 2011. First published November 2, 2010; doi:10.1152/physiolgenomics.00218.2009.-Endothelin (ET)-1 plays an important pathophysiological role in several vascular diseases including hypertension and atherosclerosis. Transgenic mice overexpressing human preproET-1 selectively in the endothelium (eET-1) exhibit vascular injury in the absence of blood pressure elevation. ET-1 overexpression may induce vascular injury by inducing changes in gene expression. To understand mechanisms whereby ET-1 induces vascular damage, vascular gene expression profiling was performed using DNA microarrays. RNA from mesenteric arteries of male and female young (6 -7 wk) and mature (6 -8 mo) eET-1 and wild-type (WT) mice was isolated, and changes in gene expression were determined by genome-wide expression profiling using Illumina microarray and FlexArray software. Data were analyzed using a relaxed and a stringent statistical approach. The gene lists were compared and analyzed as well with Ingenuity Pathway Analysis. The most common change was an increase in the expression of lipid metabolism genes. Four of these genes were validated by qPCR, cyp51, dgat2, and scd1 genes in young and elovl6 in both young and mature male mice, supporting a role of ET-1 in atherosclerosis. To test the hypothesis that ET-1 participates in mechanisms leading to atherosclerosis, we crossed eET-1 with atherosclerosisprone apoE Ϫ/Ϫ mice to determine whether ET-1 overexpression exacerbates high-fat diet (HFD)-induced atherosclerosis using oil red O staining of descending thoracic aorta. HFD increased lipid plaques by 3-, 27-, and 86-fold in eET-1, apoE Ϫ/Ϫ , and crossed mice, respectively, vs. WT. This suggests that increased endothelial ET-1 expression results in early changes in gene expression in the vascular wall that enhance lipid biosynthesis and accelerate progression of atherosclerosis. aorta; artery; lipid biosynthesis; vascular remodeling; inflammation; atherosclerosis ESSENTIAL HYPERTENSION IS characterized by increased peripheral resistance to blood flow (48). The vasoconstrictor peptide endothelin-1 (ET-1) (58), which has a critical role in normal development and probably in regulation of blood flow in normal physiology (24), has been associated with increased blood pressure (BP) in human and experimental animal studies (1, 47). ET-1 has also been implicated in other pathophysiological conditions such as pulmonary hypertension (16), atherosclerosis (4, 22, 56), heart failure (17, 19, 35, 46, 52) , myocardial infarction (8, 34), and chronic renal failure (1, 11, 37), among others (49). ET-1 is produced predominantly by endothelial cells but also by many other cells and tissues such as vascular smooth muscle cells, fibroblasts, macrophages/ monocytes and cardiomyocytes, as well as noncardiovascular cells and tissues such as renal tubular epithelial cells, glial cells, and pituitary cells (33). ET-1 acts in a paracrine manner on ET A and ET B receptors, which belong to the 7-transmembrane G protein-coupled receptor family. The signaling cascade of ET receptors in blood vessels involves phospholipase C, mitogen-activated protein kinases, phosphinositide 3-kinase, transactivation of tyrosine kinase receptors, and protein kinase C and protein kinase A, which leads to changes such as DNA and protein synthesis, proliferation, growth, migration, contraction as well as extracellular matrix remodeling (20, 51). ET-1 acts also in an autocrine manner on endothelial cell ET B receptors causing relaxation and growth inhibition via production of nitric oxide (NO) and prostacyclin (49).
aorta; artery; lipid biosynthesis; vascular remodeling; inflammation; atherosclerosis ESSENTIAL HYPERTENSION IS characterized by increased peripheral resistance to blood flow (48) . The vasoconstrictor peptide endothelin-1 (ET-1) (58) , which has a critical role in normal development and probably in regulation of blood flow in normal physiology (24) , has been associated with increased blood pressure (BP) in human and experimental animal studies (1, 47) . ET-1 has also been implicated in other pathophysiological conditions such as pulmonary hypertension (16) , atherosclerosis (4, 22, 56) , heart failure (17, 19, 35, 46, 52) , myocardial infarction (8, 34) , and chronic renal failure (1, 11, 37) , among others (49) . ET-1 is produced predominantly by endothelial cells but also by many other cells and tissues such as vascular smooth muscle cells, fibroblasts, macrophages/ monocytes and cardiomyocytes, as well as noncardiovascular cells and tissues such as renal tubular epithelial cells, glial cells, and pituitary cells (33) . ET-1 acts in a paracrine manner on ET A and ET B receptors, which belong to the 7-transmembrane G protein-coupled receptor family. The signaling cascade of ET receptors in blood vessels involves phospholipase C, mitogen-activated protein kinases, phosphinositide 3-kinase, transactivation of tyrosine kinase receptors, and protein kinase C and protein kinase A, which leads to changes such as DNA and protein synthesis, proliferation, growth, migration, contraction as well as extracellular matrix remodeling (20, 51) . ET-1 acts also in an autocrine manner on endothelial cell ET B receptors causing relaxation and growth inhibition via production of nitric oxide (NO) and prostacyclin (49) .
The generation of experimental animal models of hypertension has allowed for the study of the role of ET-1 in vascular disease. Specifically, salt-sensitive models and those with severe hypertension appear to be the ones in which ET-1 plays a role. One model of salt-dependent hypertension is the deoxycorticosterone acetate-salt hypertensive rat, which has enhanced expression of ET-1, hypertrophic remodeling of blood vessels, vascular reactive oxygen species (ROS) accumulation and endothelial dysfunction (6, 25, 26, 50) .
The generation of transgenic mice overexpressing the human preproET-1 selectively in the endothelium (eET-1) has allowed a greater understanding of the direct vascular effects of ET-1, since this mouse model is normotensive and therefore there is no confounding effect of BP elevation on vascular changes (3) . The study of 10 wk old male mice revealed vascular hypertrophic remodeling, endothelial dysfunction, and ROS accumulation (3). These mice have enhanced inflammatory responses as demonstrated by increased vascular adhesion molecules and NF-B activation (2) . Despite the link between ET-1 and these vascular changes, the mechanisms whereby ET-1 exerts these effects remain unclear. To shed light on this question, we isolated high-quality RNA from the mesenteric arteries of eET-1 and wild-type (WT) littermate mice at different ages to determine changes in gene expression using genome-wide expression profiling. We determined changes in the transcriptome of young and mature male and female eET-1 mice. The study of mice at different ages was performed to differentiate the changes in gene expression occurring early and later after ET-1-induced vascular damage was established. These experiments identified genes that might be direct or indirect ET-1 targets. We then examined crosses of eET-1 with apolipoprotein E knockout mice (apoE Ϫ/Ϫ ) mice to establish the effect that vascular gene changes induced by overexpression of ET-1 had on progression of atherosclerosis in these atherosclerosisprone mice.
METHODS

Animals.
The study was approved by the Animal Ethics Committee of the Lady Davis Institute for Medical Research (LDI) and performed according to the recommendations of the Canadian Council for Animal Care. Transgenic mice overexpressing human preproET-1 selectively in the endothelium under transcriptional control of the promoter of the endothelium-specific receptor tyrosine kinase Tie2 (eET-1) have been previously described (3) . The eET-1 and WT littermate control mice were produced by mating male eET-1 mice with WT type C57BL/6 mice. ApoE Ϫ/Ϫ mice were obtained from Jackson Laboratories (Bar Harbor, ME). ApoE Ϫ/Ϫ and eET-1/ apoE Ϫ/Ϫ crosses were generated by matting eET-1/apoE Ϫ/Ϫ and apoE Ϫ/Ϫ . Animals were housed in a controlled environment at the LDI and were provided food and water ad libitum. Four independent microarray experiments were conducted in four groups of four eET-1 and age and sex-matched littermate control mice. The four groups included 6 to 7 wk old (young) female and male mice and 6 to 8 mo old (mature) female and male mice. A separate set of young and mature mice were generated and used for plasma lipid profile determination and the microarray validation by real-time PCR. A group of 8 wk old male eET-1, apoE Ϫ/Ϫ , eET-1/apoE Ϫ/Ϫ crosses, and WT mice were fed a high-fat, cholesterol-rich diet (35% fat, 1.25% cholesterol; Research Diets, New Brunswick, NJ) diet for 8 wk and were used for determination of extent of atherosclerosis in thoracic aorta.
Blood and tissue collection and RNA extraction. Good quality RNA was obtained using RNAlater as described previously (41) with some modifications. In brief, animals were anesthetized with isoflurane inhalation. Tissues were collected in RNase-free conditions. The abdomen of the animals was shaved, cleaned with 70% ethanol, and then sprayed with RNase AWAY (Molecular BioProducts, San Diego, CA). A laparotomy was performed to expose the intestine. The entire mesenteric arcade was dissected away from the attached intestine and immediately placed in ice cold RNAlater RNA Stabilization Reagent (QIAGEN, Mississauga, ON, Canada) and incubated at 4°C overnight with gentle agitation. The mesenteric arteries as far as the 3rd order branches were dissected from surrounding fat, connective tissue, nerves, veins, and blood. RNA was extracted by homogenizing mesenteric arteries in 1 ml of TRIzol LS Reagent (Invitrogen, Carlsbad, CA) using a Polytron PT 1600 E homogenizer (Brinkmann Instruments, Mississauga, ON, Canada) equipped with a dispersing aggregate PT-DA 1607/2EC at maximum speed for 1 min and then processed as recommended by the TRIzol manufacturer up to the chloroform extraction step. RNA was further purified and isolated with RNeasy MinElute Cleanup Kit (QIAGEN) spin columns according to the company's recommendations. The concentration and purity of the RNA were assessed with a NanoDrop spectrophotometer ND-100 V3.1.2. The RNA yield per mesenteric vasculature for each mouse was on average 730 ng of total RNA in 8 l with a range of 420 -1,600 ng in 8 l. Quality of the RNA was assessed by the Functional Genomics Platform of the McGill University and Genome Quebec Innovation Center (Montreal, QC, Canada) using a bioanalyzer. For the next steps, only RNA with a RNA integrity number (RIN) of 8 or above was used. For the second group of mice used for microarray validation, animals were fasted for 6 h starting at 8 AM, anesthetized with isoflurane, and 1 ml of blood was collected on heparin by cardiac puncture before collecting the mesenteric arcade.
Microarray hybridization. Illumina BeadChip microarray assays (Illumina, San Diego, CA) were performed at the Functional Genomics Platform of the McGill University and Genome Quebec Innovation Center (Montreal, QC, Canada). For each sex and age group, in separate experiments, 250 ng of RNA of four eET-1 and four WT littermate mice was converted to cDNA and then hybridized simultaneously to a mouseRef-8 chip, which contains 25,435 probes. The BeadChip was then scanned with an Illumina BeadArray Reader. The version of the Expression BeadChip used was the MouseRef-8 V1 for the mature female mice and the updated MouseRef-8 V2 for the other three groups.
Generation of differentially expressed gene lists. Data from the Illumina BeadArray were analyzed using FlexArray Software V1.3 (Genome Quebec Innovation Center, Montreal, Canada, http:// genomequebec.mcgill.ca/FlexArray/). Raw gene expression levels were normalized by the Illumina specific Lumi Bioconductor package of the FlexArray software for each replicate (15) . The microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) (13) and are accessible through GEO Series accession number GSE19624 (http://www.ncbi. nlm.nih.gov/geo/query/acc.cgi?accϭGSE19624).
Gene lists were generated and results compared between eET-1 and WT mice for each age and sex group using two approaches. In the first approach, to decrease the possibility of false positives, gene lists were generated using two statistical tests, two sample Bayes T and cyber-T (Baldi and Long). These tests were applied to select the genes that were differentially expressed in eET-1 and WT mice. The gene lists were generated for the four groups with genes having a fold change ՆϮ1.3 and a P value Ͻ0.05 in both tests. In the second approach, the cyber-T (Bald and Long) statistical test was applied followed by a Benjamini Hochberg false discovery rate (FDR) algorithm (5) to correct for multiple testing. A gene list with those genes having a fold change ՆϮ1.3 and an adjusted P value Ͻ0.05 was generated only for the mature male mice, as the other three groups did not exhibit genes that met the above criteria.
The European Bioinformatics Institute Ensembl Genome Browser (Hinxton, Cambridge, UK) (http://www.ensembl.org/index.html) was used to classify the genes according to their function. The gene lists were also analyzed by visualizing changes in gene expression by biological function, on biological pathways, and on networks. This was done by importing gene lists into Ingenuity Pathway Analysis 7 (IPA, Ingenuity Systems, San Francisco, CA; http://www.ingenuity-.com/). IPA interprets data in the context of common molecular networks, biological processes, and pathways for genes in the dataset using information present in the literature. This software ranks top networks present in the dataset based on a score as well as top biological functions and top canonical functions based on the number of molecules. A heat map was generated with the male mature FDR-adjusted genes list using TM4 Microarray Software Suite MultiExperiment Viewer (MeV) v4.6 (Boston, MA; http://www.tm4.org/) (44, 45) showing the microarray expression values for the replicate samples.
Validation of microarray data for selected genes. The mRNA level of a selected set of genes was determined by quantitative real-time PCR (qPCR). Total RNA was extracted as described above from another set of mice and 0.45 g of RNA reversed transcribed (RT) with a Quantitect RT kit (Qiagen, Mississauga, ON, Canada). qPCR was performed using a QuantiTect SYBR Green PCR Kit (Qiagen) with the Mx3005P real-time PCR cycler (Stratagene, La Jolla, CA). qPCR results were normalized with ribosomal small protein S16 (Rps16) and expressed as fold change over WT control. Primers were designed using Primer3. (43) Annealing temperature was 58°C. The list of primer sequences is presented in Supplemental Table S1 . Quantification of atherosclerosis. Mice were anesthetized with isoflurane. The descending thoracic aorta was dissected, the adventitial fat was carefully removed, and the aorta was fixed in 4% paraformaldehyde for 1 h at room temperature followed by a rinse with water. Aortic plaques were quantified by oil red O staining. The aorta was opened longitudinally and stained in 0.5% oil red O working solution (Electron Microscopy Sciences, Hatfield, PA) for 30 min. The tissue was rinsed three times for 5 min with water and pinned on white wax in a Petri dish or mounted en face on a microscope slide and coverslipped with Immu-Mount mounting solution (Thermo Scientific, Pittsburgh, PA). Aorta images were captured and plaques quantified with Infinity capture imaging and analysis software (Luminera, Ottawa, ON, Canada), respectively. Atherosclerotic lesions are shown as a percentage of lipid-staining area over total vascular area.
Statistical analysis. Results are presented as gene lists, heat maps, or as means Ϯ SE. Comparison between eET-1 and WT mice in the microarray study was made by two-sample Bayes T and cyber-T (Baldi and Long) and by cyber-T (Baldi and Long) followed by FDR testing. Comparisons between multiple groups were done by one-way ANOVA followed by a Student-Newman-Keuls post hoc test. Comparisons between two groups were done by Student t-test. P Ͻ 0.05 was considered statistically significant.
RESULTS
Gene expression profiling in male and female eET-1 mice.
Mesenteric artery RNA from mature male and female eET-1 and WT sex-matched littermates was studied on two separates Illumina BeadChips in two separate experiments using twosample Bayes T and cyber-T (Baldi and Long) as described above. A total of 191 transcripts were differentially expressed between male eET-1 and WT littermate mice. Of these, 103 genes were upregulated and 88 genes were downregulated (Table 1) . Genes were classified according to their function using information available on the Ensembl Genome Browser. These results are depicted in Supplemental Table S2 and as a heat map in Supplemental Fig. S1 . Differently regulated genes were distributed in several categories, including 7 in functions related to transcription and translation, 11 in growth and apoptosis, 16 in signal transduction, 16 in inflammation and adhesion, 27 were proteases, and 64 involved in metabolism. Most of the metabolic genes were implicated in lipid metabolism (31/64). Many of the lipid metabolic genes concern lipid biosynthesis (16/31) and were primarily upregulated, whereas lipid catabolic genes (7/31) were mostly downregulated in eET-1 mice (Table 1) . Twenty-seven genes were involved in miscellaneous functions. The above gene list was analyzed on known maps and pathways using IPA software. The IPA top associated network functions were related to lipid metabolism, with inflammatory functionally related networks ranking second and fourth (Table 2) . Lipid metabolic genes also ranked first as a top biological function. The 2nd, 3rd, 5th, and 8th ranks of the IPA top canonical pathways were lipid metabolic pathways. Altogether, these results suggest an increase in lipid biosynthesis in male eET-1 mice compared with WT littermate mice.
In female mice, 64 transcripts were differentially expressed in eET-1 compared with WT littermate mice. Forty genes were upregulated and 24 downregulated (Table 1 ). Differently regulated genes were distributed in several categories, presented in Supplemental Table S3 and as a heat map in Supplemental Fig. S2 . These genes included 5 involved in growth and apoptosis, 5 were membrane-associated, 7 related to signal transduction, 8 to metabolism, 10 to transcription and translation, and 23 to inflammation and adhesion. Most of the latter were proinflammatory (19/23), such as cytokines and chemokines, and were upregulated ( Table 1 ). The analysis of the mature female eET-1 genes that were altered using known maps in IPA revealed that one of the first ranked top associated network function was antigen presentation (Table 2 ). In addition, six of the IPA top biological functions were inflammation and immune responses. Most of the IPA top canonical pathways were also associated to inflammation and immune re- Changes in gene expression in mesenteric arteries were determined in female and male mature (6 -8 mo old) and young (6 -7 wk old) transgenic mice with endothelium-restricted human preproendothelin-1 overexpression compared with wild-type (WT) littermate mice using microarrays as described in METHODS. Genes with significantly (P Ͻ 0.05) altered expression levels were grouped manually into gene function categories as described in METHODS. Results are presented as number of differentially expressed genes and as the percentage of altered genes in parentheses; n ϭ 4 per group. sponses. Interestingly, renin-angiotensin signaling was among the top canonical pathways. Thus, mesenteric arteries of mature female eET-1 mice appear to be associated with a proinflammatory environment. Accordingly, gene expression in mature males showed differences with mature females. Only two genes were similarly changed in mature male and female mice, one related to inflammation and adhesion (Retnla) and one to signal transduction (Pim3) ( Table 3) . Some of the changes in gene expression observed in the mature eET-1 mice could be the result of adaptation to chronic ET-1 exposure. To determine the primary targets of ET-1, the transcriptome of young mice was characterized and compared with that of mature mice. Mesenteric artery RNA of young male and female eET-1 and WT sex-matched littermates was studied on two separate Illumina BeadChips in two different experiments. The young male eET-1 mice were similar to their older male counterparts. In young male eET-1 mice, 96 genes were differentially expressed, 43 upregulated and 53 downregulated (Table 1) . Differently regulated genes were distributed in several categories, which are presented in Supplemental  Table S4 and as a heat map in Supplemental Fig. S3 . They included 9 genes related to signal transduction, 14 involved in inflammation and adhesion, 14 in transcription and translation, and 27 in metabolism. The majority of these metabolic genes were involved in lipid metabolism (15/27), with lipid biosynthetic genes upregulated (Table 1 ). There were 12 miscellaneous genes. The integration of the young male eET-1 altered gene list into known maps in IPA revealed that lipid metabolism appeared as one of the functions in two of the five IPA top associated network functions ( Table 2 ). The nuclear signaling LXR/RXR pathway and circadian rhythm signaling were among the five top canonical pathways and were involved in lipid and cholesterol metabolism. In addition, the first IPA top biological functions and two of the five top canonical pathways were associated with inflammation and the immune response.
Young female eET-1 mice presented 119 altered genes of which 54 were upregulated and 65 downregulated (Table 1) . Differently regulated genes were distributed in several categories, presented in Supplemental Table S3 and as a heat map in Supplemental Fig. S4 . Among these genes, 11 were membrane-associated, 13 were related to signal transduction, 13 involved in transcription and translation, 23 in inflammation and adhesion, and 33 in metabolism ( Table 1 ). The majority of the genes involved in lipid metabolism (16/27) were upregulated lipid biosynthetic genes. There were 11 miscellaneous genes. The integration of the young female eET-1 gene list into IPA showed lipid metabolism as a major function in three out of the five top network functions as well as in the 10 top biological functions ( Table 2) . Three of the top canonical pathways were associated with lipid metabolism. Although lipid accumulation appeared to be the predominant function present in this gene list, there were still some inflammatory and immune response genes present as two of the top canonical pathways.
Comparison of the lists of differentially expressed genes in young male and female animals revealed that seven genes were co-regulated, of which four are involved in lipid biosynthesis (Table 3) . Thus, young male and female mice behaved similarly, with lipid biosynthesis as an early, primary response to ET-1 overexpression. Furthermore, one heme biosynthesis gene (alas2) and one anion exchange protein gene (slc4a1) were similarly regulated in both groups. Comparison of female mice at both ages showed that their genes behaved differently, since only three genes were similarly regulated, interestingly all of them overexpressed inflammatory genes (Table 3) . It thus appears that as females age, they behave differently in response to ET-1 overexpression. One of the three genes, retnla, was also co-regulated in mature males (see above). In contrast to females, males at both ages showed some similarity, with 20 genes similarly regulated, including 9 genes implicated in lipid biosynthesis (Table 3) . Four of the lipid biosynthetic genes, acaca, dgat2, elovl6 and scd1, were also co-regulated in the young female eET-1 mice (Table 3 ). The co-regulation of lipid biosynthetic genes in young male and female mice and mature male eET-1 mice suggests a role of these in eET-1-associated vascular injury. Other co-regulated genes (alas2, ddah1) might also be implicated in ET-induced endothelial dysfunction and remodeling. Alas2 encodes a rate-limiting enzyme that catalyzes the first step of the heme biosynthetic pathway (18) . Heme is a constituent of NO synthase, soluble guanylyl cyclase (sGC), and heme oxygenase (HO), all important in the regulation of vascular tone (21) . Ddah1 contributes to catabolize asymmetric dimethylarginine (ADMA) and NG-monomethyl-L-arginine (MMA), which are inhibitors of NO synthase and Ingenuity Pathway Analysis top networks, functions and pathways were generated for lists of differentially expressed genes in mesenteric arteries of transgenic mice with endothelium-restricted human preproendothelin-1 overexpression and compared to wild-type littermate mice using microarrays analyzed using two statistical tests, 2-sample Bayes T and cyber-T (Baldi and Long), as described in Methods. Ranked by score or P-value. n ϭ 4 per group. Common changes between different groups in gene expression in mesenteric arteries of transgenic mice with endothelium-restricted human preproendothelin-1 overexpression compared to wild-type littermate mice using microarrays using two statistical tests, 2-sample Bayes T and cyber-T (Baldi and Long), as described in METHODS. Genes with significantly (P Ͻ 0.05) altered expression levels of Ϯ1.3-fold were grouped manually into categories as described in Methods. Increases and decreases in gene expression are indicated with light or boldface type, respectively. n ϭ 4 per group. Chr is Chromosome. thus affect endothelial function (10) . Hk2 and bmp4 could also be important for vascular remodeling (54) . Angptl7 might also be an interesting candidate gene mediating some ET-1 effects. It is an angiopoietin-like factor, which could be important for angiogenesis and lipid metabolism (reviewed in Ref. 23 ). Three co-regulated genes in the inflammatory and adhesion category could play a role in ET-1 effects. In particular, nfil3, also known as e4bp4, has been shown to be a critical transcription factor for natural killer (NK) cell development (12) , and could participate in ET-1-induced vascular inflammation (2) . Finally, 3 genes in the transcription and translation category and nfil3 could be of interest as they are circadian clock genes and might be involved in lipid metabolism, hypertension, and diabetes (7, 53, 57) .
The microarray data were also analyzed with a more robust statistical approach using the cyber-T (Bald and Long) statistical test followed by a Benjamini Hochberg FDR algorithm to correct for multiple testing. Using this approach, a list of genes was generated only for the mature male mice as the other three groups did not meet the required criteria. A total of 62 transcripts were differentially expressed in male eET-1 and WT littermate mice. Of these, 46 genes were upregulated and 16 genes were downregulated. These genes were classified according to their function as above and are presented in Supplemental Table S6 and in Fig. 1 as a heat map. Differently regulated genes were distributed in several categories, including functions related to transcription and translation, growth and apoptosis, signal transduction, inflammation and adhesion, proteases, membrane associated, cytoskeleton, metal binding, and 25 involved in metabolism. More than half of the metabolic genes were implicated in lipid metabolism (14/25) . Most of the lipid metabolic genes concerned lipid biosynthesis (9/14) and were upregulated in eET-1 mice. Nine genes were involved in miscellaneous functions. The above gene list was analyzed using known maps and pathways with IPA. Three of the four IPA top associated network functions were related to lipid metabolism (Table 4) . Lipid metabolic genes also ranked as a top biological function. The third to fifth ranks of the IPA top canonical pathways were lipid metabolic pathways. Altogether, as suggested with the first analysis performed above, these results are in agreement with an increase in lipid biosynthesis in mature male eET-1 mice compared with WT littermate mice.
Validation of microarray results of mature and young male mice. Some changes observed in mature and young male mice using microarray experiments were validated by qPCR. As the robust and the less stringent analyses above revealed that the most common change in gene expression observed in mature and young male was in lipid biosynthesis, five lipid genes were studied, ch25h, cyp51, dgat2, elovl6, and scd1. Four other genes involved in metabolism (Acss1), signal transduction (sostdc1), membrane associated (slc25a10), and differentiation and development (bmp4) were also selected for validation. It is noteworthy that seven of the nine genes were selected on the base that they were co-regulated in mature and young male mice. In mature male mice, one lipid gene, elovl6 was increased and validated the microarray data ( Fig. 2A) . Three genes tended to increase and validate the microarray data, scd1, sostdc1, and slc25a10. In young male mice, four lipid genes and one membrane-associated gene were increased and validated the microarray data, cyp51, dgat2, elovl6, and scd1 and slc25a10. Altogether, these results show again that there could be an increase in lipid biosynthesis in male eET-1 mice compared with WT littermate mice.
Plasma lipids were not altered in eET-1 mice. Changes in lipid gene expression may predispose eET-1 mice to develop dyslipidemia. To verify this hypothesis, the plasma lipid profile Fig. 1 . Differentially expressed genes in the mesenteric arteries of mature male eET-1 mice compared with wild-type (WT) littermate. The microarray data for the mature male eET-1 and WT were analyzed using the cyber-T (Bald and Long) statistical test followed by a Benjamini Hochberg false discovery rate (FDR). The genes were classified according to their function, and the list was used to generate a heat map using MeV software.
was determined in young and mature male mice after 6 h fasting. No significant difference in plasma TG, cholesterol, or HDL was observed in eET-1 and WT mice in either young or mature groups (Fig. 3) .
Elevated lipid gene expression is associated with exacerbation of atherosclerosis in apoE knockout mice on a highcholesterol diet. ET-1 has been implicated in the development of atherosclerosis. The plasma and arterial tissue ET-1 levels are increased in animals and patients with atherosclerosis (27, 28, 36, 39) . ET-1-induced increase in expression of genes involved in lipid biosynthesis might play a role in the development of atherosclerosis. To test this hypothesis, we crossed eET-1 mice with atherosclerosis-prone apoE Ϫ/Ϫ mice to determine whether ET-1 overexpression exacerbates high-fat diet (HFD)-induced atherosclerosis. The extent of atherosclerotic plaque development was determined in the descending thoracic aorta of 8 wk old WT, eET-1, apoE Ϫ/Ϫ , and eET-1/apoE Ϫ/Ϫ crossed mice fed an HFD for 8 wk by determining the percentage of lipid area with oil red Ostained area. HFD increased atherosclerotic lesion size by 3-and 27-fold in eET-1 and apoE Ϫ/Ϫ , respectively, compared with WT (Fig. 4) . This was exacerbated in crossed mice 
Acat2, acss2, ldha
Ingenuity Pathway Analysis top networks, functions and pathways were generated for lists of differentially expressed genes in mesenteric arteries of mature male transgenic mice with endothelium-restricted human preproendothelin-1 overexpression and compared to wild-type littermate mice using microarrays using the cyber-T (Bald and Long) statistical test followed by a Benjamini Hochberg False Discovery Rate (FDR) algorithm to correct for multiple testing as described in Methods. Ranked by score or P value. n ϭ 4 per group. 
DISCUSSION
The present study reveals important mechanistic clues of how ET-1 overexpression induces vascular damage leading to atherosclerosis. These mechanistic insights were achieved by determining the changes in gene expression in mesenteric arteries of eET-1 vs. WT littermate mice using genome-wide expression profiling. Since changes in gene expression could be due to adaptation to chronic ET-1 exposure, we compared mature and young male and female mice. The comparison of the male and female and of mature and young mice allowed discovery of co-altered gene expression in eET-1 mice, which could lead to increased lipid biosynthesis and contribute to vascular remodeling and endothelial dysfunction and development of atherosclerosis. When eET-1 mice were crossed with apoE Ϫ/Ϫ mice and fed an HFD, progression of atherosclerosis was dramatically enhanced. Thus, the biological correlate of the increase in lipid biosynthetic genes found in the aortic wall of eET-1 mice was demonstrated.
Comparison of results of genome-wide expression profiling in young and mature male and female mice with the less stringent statistical approach [genes commonly changed significantly in the two-sample Bayes T and the cyber-T (Baldi and Long) test] and the more stringent [cyber-T (Bald and Long) followed by an FDR] approach showed co-regulation in young and mature male and/or in young female mice of acaca, ch25h, cyp51, dgat2, elovl6, and scd1. However, mature female eET-1 behaved differentially and demonstrated a majority of proinflammatory gene upregulation. The robust statistical approach showed significant changes in gene expression only in mature male mice. The lack of significant change in the three other groups could be due to higher variability of the data. The most important changes in gene expression revealed by the IPA was in lipid biosynthesis. Genes that were commonly changed in both less and more stringent analysis in mature male and in young male and/or young female mice were ch25h, cyp51, dgat2, and elovl6, and of these, cyp51, dgat2, elovl6, and scd1 genes were validated in young male mice, whereas in mature male mice elovl6 could be validated and scd1 only exhibited a trend that did not achieve significance. Slc25a10 was validated in young mice and showed a trend without achieving significance in mature male mice. The latter gene encodes the mitochondrial dicarboxylate transporter. However, no role could be attributed to this gene with regard to vascular pathology. Further studies will be required to characterize the other genes that were identified. The increase of the four lipid biosynthetic genes favor the accumulation of lipids such as TG and could predispose eET-1 mice to develop dyslipidemia and atherosclerosis. Cyp51 encodes cytochrome P450, family 51. It converts lanosterol to cholesterol. Cyp51 is regulated by cholesterolemia and by oxysterols. Hypercholesterolemia decreases the expression of this gene, and oxysterol has been shown to decrease the expression of cyp51 in adrenocortical H295 and hepatoma cells (42) . Dgat2 encodes diacylglycerol O-acyltransferase 2 and catalyzes the final step in the production of TG. Accumulation of this neutral lipid has been associated with insulin resistance and the expression of dgat2 is increased in diabetic mice (55, 59) . In addition, transgenic mice overexpressing dgat2 in glycolytic muscle presented increased TG accumulation and insulin resistance (29) . Reducing the expression of dgat2 in liver and fat in obese animals did not decrease body weight but resulted in reduced liver TG content and attenuated hyperlipidemia and development of a fatty liver, leading to improvement of the metabolic syndrome (59) . These mice also exhibited a decrease in gene expression of other lipogenic genes such as fatty acid synthase (fas), scd1, and acaca. Both elovl6 and scd1 are involved in TG biosynthesis. Elovl6 encodes elongation of very long chain fatty acid protein 6 and is involved in the formation of long-chain fatty acids and TG biosynthesis (31) . Elovl6 Ϫ/Ϫ mice are resistant to high-fat and sucrose diet-induced insulin resistance (32) . It is important to note that the knockout of elovl6 decreases the expression of scd1, which encodes stearoyl-coenzyme A desaturase 1 that converts saturated fatty acids into monounsaturated fatty acids (MUFA), which are substrates for the formation of complex lipids such as the TG, cholesterol ester, wax esters, and diacyglycerols (14) . Scd1 Ϫ/Ϫ mice and mice treated with scd1 antisense oligonucleotides have a reduction in MUFA synthesis and are protected from obesity, cellular lipid accumulation, and insulin resistance (reviewed in Ref. 14) . Deletion of scd1 gene reduces the development of metabolic syndrome (reduces plasma TG, reduces weight gain, and increases insulin sensitivity) in severely hyperlipidemic low-density lipoprotein receptor-deficient mice fed a Western diet (30) . Both laminar shear stress and the PPAR␥ agonists, troglitazone and rosiglitazone, increased the gene expression of scd1 in endothelial cells (38) .
The examination of the lipid plasma profile indicated that young and mature eET-1 mice do not present the characteristics of the metabolic syndrome or dyslipidemia at baseline. However, the increased expression of lipid biosynthetic genes could predispose eET-1 to develop dyslipidemia, atherosclerosis or the metabolic syndrome. ET-1 is increased in plasma and coronary arteries in early and advanced atherosclerosis in humans (27, 28) . ET-1 overexpression exacerbated the development of lipid plaques in the descending thoracic aorta of atherosclerosis-prone apoE Ϫ/Ϫ mice under an HFD in the present study. Furthermore, the overexpression of ET-1 in eET-1 mice was sufficient to increase significantly the development of lipid plaques after only 8 wk of HFD. These results suggest that increased endothelial ET-1 expression results in early changes in gene expression in the vascular wall enhancing lipid biosynthesis, which exacerbates HFD-induced atherosclerosis.
The results described lead to the conclusion that an increase in lipid biosynthesis in male eET-1 mice seems to be a primary result of ET-1 overexpression, which persists as the animal ages, at least in males. Lipid biosynthetic genes cyp51, dgat2, elovl6, and scd1, whose expression is increased in young male eET-1 mice, and elovl6, with increased expression persisting in mature male eET-1 mice, may be primary ET-1 targets. It will be of interest to determine if inhibition of these genes will attenuate any of the deleterious effects of ET-1 overexpression. The increase in lipid biosynthetic genes may also occur in young female mice, but this needs to be further studied.
This genome-wide expression profiling study might have been limited in part by variability of the data. This could be due to the difficulty in isolating sufficient amounts of undegraded RNA from mesenteric arteries. The RNA yield was just enough to check the RNA quality and to prepare the cDNA. In addition, we found that the mesenteric arteries were very rich in RNase, which has complicated the obtention of undegraded RNA. To obtain good-quality data, we were careful to use RNA extracted from arteries with an RIN of 8.
As already mentioned, increased inflammation and adhesion have already been demonstrated in eET-1 mice. The increased inflammatory response may be the result of direct action of ET-1 or may be due to other mechanisms. Since many lipid biosynthetic genes were increased in eET-1 mouse blood vessels, the increased lipid accumulation could be contributing to ET-1-induced inflammation leading to endothelial dysfunction, vascular remodeling, and acceleration of progression of atherosclerosis as demonstrated by our eET-1/apoE Ϫ/Ϫ crosses. ET-1 may be increasing lipid gene expression via cross talk with the nuclear receptor transcription factors LXR/RXR or PXR/RXR, pathways that were upregulated in young female and male eET-1 mice. Rabbits fed an HFD have an increase in blood lipid levels as well as inflammatory markers such as IL-6 (9). These rabbits also display increased ET-1 and endothelial dysfunction (9) . Therefore, high fat is capable of inducing inflammation, leading to endothelial dysfunction in association with elevated vascular ET-1. Furthermore, as indicated above, plasma and coronary ET-1 levels are increased in atherosclerosis (27, 28) . Interestingly, it has been shown recently that treatment with an ET A receptor antagonist atrasentan improves coronary microvascular endothelial function in early atherosclerosis in humans (40) .
Conclusions
We demonstrate for the first time the vascular gene expression pattern in mice overexpressing human ET-1 selectively in the endothelium, in which we previously demonstrated that ET-1 leads to endothelial dysfunction and vascular remodeling in part via increased oxidative stress and inflammation. We also demonstrate the acceleration of progression of atherosclerosis by crossing eET-1 with apoE Ϫ/Ϫ exposed to an HFD. The latter provides a biological proof for the gene changes in the wall of eET-1 mice. Our results suggest that ET-1 may lead to these changes by inducing lipid accumulation. These results have the potential to identify new ET-1 gene targets, which may facilitate the discovery of new therapeutic approaches to block the effects of the ET system in humans. This can ultimately lead to a reduction in the complications of different forms of cardiovascular disease in which ET-1 has been shown to be implicated such as hypertension, atherosclerosis, heart failure, diabetes mellitus, metabolic syndrome, and atherosclerosis.
